1. Molecular Gene Therapy: Overexpression of the Alternative NADH Dehydrogenase NDI1 Restores Overall Physiology in a Fungal Model of Respiratory Complex I Deficiency
- Author
-
Carole H. Sellem, Annie Sainsard-Chanet, Frank Krause, Norbert A. Dencher, and Marc F.P.M. Maas
- Subjects
chemistry.chemical_classification ,Reactive oxygen species ,Electron Transport Complex I ,biology ,NADH dehydrogenase ,Respiratory chain ,Wild type ,NADH Dehydrogenase ,Genetic Therapy ,Oxidative phosphorylation ,biology.organism_classification ,Podospora anserina ,Mitochondria ,Cell biology ,Electron Transport ,chemistry ,Biochemistry ,Podospora ,Structural Biology ,Coenzyme Q – cytochrome c reductase ,biology.protein ,Apoptosis-inducing factor ,Molecular Biology - Abstract
Defects in oxidative phosphorylation lie at the heart of a wide variety of degenerative disorders, cancer, and aging. Here, we show, using the fungal model Podospora anserina, that the overexpression of the native mitochondrial matrix-faced type II NADH dehydrogenase NDI1, paralogue of the human apoptosis inducing factor AIF1, can fully restore all physiological consequences of respiratory complex I deficiency. We disrupted the 19.3-kDa subunit of the complex I catalytic core, orthologue of the human PSST subunit, leading to a complete absence of the complex without affecting the assembly and/or stability of the rest of the respiratory chain. This disruption caused a several-fold life span extension at the expense of both male and female fertility. The effect was generally similar but markedly milder than that caused by defects in the complex III/IV-dependent pathway and not associated with a clear reduction in the steady-state level of mitochondrial reactive oxygen species. Whereas the native expression of NDI1 was sufficient to overcome lethality, only the artificial, constitutive overexpression of NDI1 could fully remedy this deficiency: The latter strikingly restored both life span and fertility to levels indistinguishable from wild type, thus demonstrating its unique potential in molecular gene therapy.
- Published
- 2010
- Full Text
- View/download PDF